OncoRes Medical Receives Breakthrough Device Designation
OncoRes Medical has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) to expedite development of our Quantitative Micro-Elastography (QME) Imaging System. Please see media case study here.
OncoRes Medical Receives $150,000 Funding Boost from Western Australian Government
Innovation and ICT Minister Dave Kelly today announced the McGowan Government will invest $150,000 in funding from the New Industries Fund into Western Australian-based medical device start-up OncoRes Medical to enhance R&D capability and create local jobs at their Nedlands-based facility.
Perth-based medtech company, OncoRes Medical, has taken out the IGNITE Madness pitch competition in Houston, Texas, USA. In addition to the US$10,000 first prize, OncoRes Medical was awarded the prestigious Texas Medical Centre Ventures investment prize which is valued in excess of US$100,000.
Together with Federal Minister for Health The Hon Greg Hunt MP, we are very excited to announce the OncoRes Medical has been awarded $1 million funding as part of the Australian Government’s Medical Research Future Fund BioMedTech Horizons program, following a competitive application process. OncoRes Medical will be utilising the funds to develop a compact wireless technology for improved accuracy during breast conserving surgery.
OncoRes Medical wins AusBiotech and Johnson & Johnson Innovation Industry Excellence 'Emerging Company of the Year' Award.
We would like to thank the Australian life sciences community for the incredible support they have shown OncoRes Medical over the last three years. Receiving the Emerging Company of the Year award at The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards is recognition of the hard work our entire team continues to undertake, as we work to improve outcomes for cancer patients globally. We’re thrilled to receive this award and look forward to keeping you updated on our progress.